The FDA posted a voluntary recall of one Baxter IV cefazolin in dextrose lot after particulate matter described as “cardboard” was found in the solution. If you (or a loved one) may have received doses from that lot, the best next step is to ask the facility that gave the medication to confirm the lot—then use a symptom “watch list” for urgent breathing/chest, sudden circulation, or IV-site vein problems.
CDC’s weekly measles wastewater updates can offer an early community signal. Here’s how to interpret “detected,” “not detected,” and “no data,” plus what families should do if exposure is possible—especially for infants, pregnant people, and immunocompromised household members.
CDC says the overall risk to people in the United States from the current Bundibugyo Ebola outbreak is low, with a very low likelihood of spread. But CDC still asks travelers to follow specific precautions—and to isolate and call ahead if they develop Ebola-like symptoms within 21 days after travel.
Calling or texting 988 connects you with immediate crisis support. “Crisis center follow-up” is the next step—aimed at making sure people who may still be at risk are connected to stabilization, respite, and ongoing care after the call ends.
CMS will enforce revised CY 2026 Hospital Price Transparency machine-readable file requirements starting April 1, 2026. This guide explains the updated allowed-amount data elements, how CMP reductions work, and how to read CMS’s enforcement dataset—plus why transparency doesn’t automatically make bills affordable.
A tooth abscess can start as severe tooth pain and swelling—but it can also spread and become life-threatening. Use this “don’t wait” checklist to know when to call a dentist vs. go to the ER.
FDA says American Regent is voluntarily recalling one lot of papaverine hydrochloride injection because vials may contain visible particulate matter. This guide explains how to check the lot, what to do if you have the affected product (or already received it), and when stroke-like symptoms mean “call 911.”
A positive COVID-19 test is a “call today” moment. This explains what to do right away to avoid missing outpatient treatment windows, who may qualify, and how HHS/FDA’s COVID-19 EUA transition could affect families and caregivers over time.
On June 3, 2026, the FDA updated its safety communication for the Hintermann Series H3 total ankle replacement. If your ankle is working well, FDA does not recommend surgery to remove the implant—but you should keep follow-up appointments and contact your clinician promptly if you notice new or worsening symptoms such as pain, swelling, inability to bear weight, instability, unusual noises, or weakness around the device.
A new randomized trial of remote, individualized, goal-focused cognitive rehabilitation for Long COVID brain fog found better “goal attainment” at 3 months—and the improvement persisted at 6 months. The benefits weren’t broad across all cognitive tests or every symptom, but they offer a practical model for function-focused rehab planning and for work accommodations planning in the U.S.
CMS will begin enforcing updated hospital price transparency requirements for CY 2026 on April 1, 2026. The goal is to make it easier to compare prices before care—but posted hospital charges still won’t perfectly predict what you’ll pay after insurance. Here’s what CMS requires, how to read CMS’s enforcement dataset, what the data can’t tell you about your out-of-pocket bill, and a simple checklist for using posted pricing responsibly.
If you’ve had watery diarrhea after eating certain iceberg lettuce, CDC and FDA say it may be linked to Cyclospora. Here’s how to replace fluids and electrolytes, what to tell your clinician about testing, and when diarrhea symptoms mean you should get urgent medical help.
On July 14, 2026, FDA asked the public for input as it prepares its next report on “non-device software functions,” including certain forms of limited clinical decision support. Here’s what FDA is asking—and practical ways patients, caregivers, and clinicians-adjacent readers can verify AI-generated health guidance before acting on it.
FDA advised that the U.S. 2026–2027 seasonal COVID-19 vaccine should use a monovalent JN.1-lineage XFG target for use beginning in fall 2026. Here’s what a “formula update” changes, how families can think about timing with CDC guidance, who should be especially deliberate, and what Medicare beneficiaries may want to check for access.
Anaphylaxis is a medical emergency. Use your prescribed intranasal (nasal) epinephrine at the first signs, repeat after 5 minutes if symptoms aren’t improving, and call 911—then go to the ER for emergency treatment and monitoring.
On July 1, 2026, the FDA expanded Casgevy (exagamglogene autotemcel) so some children with sickle cell disease (SCD) as young as age 2 can be evaluated for this one-time, CRISPR-based gene therapy. Here’s what changed, what the trial endpoints measured, what families can expect during treatment, and what safety and long-term follow-up questions still matter.
Starting with 2027 plan years, HRSA-updated cervical cancer screening guidance includes an option for eligible patients to self-collect a sample for high-risk HPV (hrHPV) testing. Here’s who qualifies, how self-collection works, the usual screening intervals, and what to do if your result is positive.
CMS finalized the 2027 ACA Health Insurance Marketplace rules that tighten eligibility verification—especially for some people enrolling through Special Enrollment Periods—and put safeguards around premium tax credit eligibility. The rule also lowers Exchange user fees, which could affect insurer pricing, but the consumer impact isn’t fully predictable. Here’s what to expect for 2027 enrollment paperwork, subsidy timing, and help if verification stalls.
FDA posted a voluntary nationwide recall (July 24, 2026) of one lot of Baxter IV cefazolin in dextrose bags after cardboard-type particles were reported in the solution. Here’s how to confirm the exact lot, what symptoms to watch for, and what your care team should review.
Measles activity has been rising in the United States in 2026, and schools and families are again fielding questions about MMR records—especially when records are missing or incomplete. This step-by-step guide explains how “vaccinated” is typically determined from documentation, what to do while you’re waiting to confirm, and what to do fast after a known exposure. CDC guidance is clear on timing: MMR can help within 72 hours for many people without evidence of immunity, and immune globulin may be an option within 6 days for specific higher-risk situations. Learn what caregivers should watch for at home—plus what families with immunocompromised children should plan with clinicians and public health.
Wildfire smoke can irritate airways and trigger asthma symptoms—especially in children, older adults, and people with lung or heart conditions. The good news: you can make a simple “smoke plan” around air quality (AQI), cleaner indoor air, and the right kind of particle protection. This guide walks you through what to do before smoke gets bad, how to reduce exposure at home (including MERV 13 filtration), what to watch for in kids and other higher-risk family members, and the plain-language danger signs that mean it’s time to call for emergency help.
CDC says to stop using a recalled Nara Organics powdered infant formula if your baby may have had it, and to watch for infant botulism warning signs for up to a month after last use. Get emergency care right away if you notice feeding/swallowing changes, decreased facial expression, or head control weakness.
End of content
End of content